hrp0097p1-497 | GH and IGFs | ESPE2023

First-year response to growth hormone (rGH) treatment and assessment of iGRO software for the prediction of growth velocity.

Kosteria Ioanna , Atnanasouli Fani , Dikaiakou Eirini , Leka-Emiris Sofia , Vlachopapadopoulou Elpis-Athina

Objectives: Response to rGH during the first year of treatment is considered indicative of its effectiveness for the improvement of final height. The iGRO software assesses the response to rGH in children with idiopathic growth hormone deficiency (IGHD) or small for gestational age (SGA) based on age, gender, gestational age, birthweight, rGH dose, maximal GH during stimulation tests, as well as weight and height measurements on follow-up visits. The aim was t...